Alyssa Gayle Caplan, MD
Gastroenterology · San Carlos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 3 carriers
- Office
- 1
- Since medical school
- 7 years
- Graduated 2019
Offices
1 location · Digestive Care Associates, A Medical Corporation · 7 clinicians in this group
Looking this up.
Hospitals listed: Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
5 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Caplan’s office at (650) 596-8800 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 13 | More than 43% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Drugs they prescribed that Part D paid
$6,686
Pharmacies billed $6,686 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 13) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
11 generic and fewer than 11 brand-name prescriptions · $6,686 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 13 | None | 0% (0) | None | $6,686 |
| 2023 | 14 | None | 0% (0) | 0% | $454 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$1,044 in 2025
| 2025 | 12 | 32 | None | $1,044 |
| 2024 | 3 | 3 | $500 | $673 |
| 2022 | 1 | 1 | None | $18 |
| 2021 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Madrigal Pharmaceuticals | Rezdiffra | $289 | 5 payments
|
| Abbvie | Creon | $204 | 8 payments
|
| Janssen Biotech | Tremfya | $96 | 3 payments
|
| Ardelyx | Ibsrela | $90 | 3 payments
|
| QOL Medical | Sucraid | $63 | 2 payments
|
| Celltrion USA | Vegzelma | $57 | 2 payments
|
See all 32 published payments
| Abbvie | Meals · 2025-12-06 | Creon | $24 |
| Pfizer | Meals · 2025-12-02 | Velsipity | $28 |
| Madrigal Pharmaceuticals | Meals · 2025-12-02 | Rezdiffra | $34 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-11-24 | Entyvio | $24 |
| Abbvie | Meals · 2025-11-18 | Rinvoq | $21 |
| Ardelyx | Meals · 2025-11-17 | Ibsrela | $31 |
| Abbvie | Meals · 2025-11-12 | Creon | $29 |
| Madrigal Pharmaceuticals | Meals · 2025-11-11 | Rezdiffra | $31 |
| Janssen Biotech | Meals · 2025-11-04 | Tremfya | $29 |
| Celltrion USA | Meals · 2025-11-04 | Vegzelma | $29 |
| Novo Nordisk | Meals · 2025-10-30 | Wegovy | $27 |
| Abbvie | Meals · 2025-10-29 | Creon | $27 |
| Madrigal Pharmaceuticals | Meals · 2025-10-29 | Rezdiffra | $139 |
| Ipsen Biopharmaceuticals | Meals · 2025-10-23 | Iqirvo | $34 |
| Abbvie | Meals · 2025-10-21 | Rinvoq | $27 |
| QOL Medical | Meals · 2025-10-20 | Sucraid | $31 |
| Aimmune Therapeutics | Meals · 2025-10-15 | Zenpep | $29 |
| Ardelyx | Meals · 2025-10-14 | Ibsrela | $31 |
| Madrigal Pharmaceuticals | Meals · 2025-10-14 | Rezdiffra | $41 |
| Pfizer | Meals · 2025-10-11 | Velsipity | $24 |
| Abbvie | Meals · 2025-10-08 | Rinvoq | $20 |
| Celltrion USA | Meals · 2025-10-01 | Vegzelma | $29 |
| Exact Sciences | Meals · 2025-09-30 | Cologuard Collection Kit | $34 |
| Madrigal Pharmaceuticals | Meals · 2025-09-26 | Rezdiffra | $44 |
| Ardelyx | Meals · 2025-09-23 | Ibsrela | $28 |
| Novo Nordisk | Meals · 2025-09-22 | Wegovy | $25 |
| Abbvie | Meals · 2025-09-15 | Linzess | $26 |
| Abbvie | Meals · 2025-09-12 | Skyrizi | $30 |
| Janssen Biotech | Meals · 2025-09-09 | Tremfya | $26 |
| QOL Medical | Meals · 2025-09-08 | Sucraid | $32 |
| Janssen Biotech | Meals · 2025-04-15 | Tremfya | $41 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-11 | Entyvio | $19 |
See earlier years (2024, 2022, 2021)
2024: $673
| Neptune Medical | None | $500 | 1 payment
|
| Mallinckrodt Hospital Products | Terlivaz | $146 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $27 | 1 payment
|
2022: $18
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
2021: $20
| E.R. Squibb & Sons L.L.C. | Eliquis | $20 | 1 payment
|
Professional record
- NPI
- 1144781915
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 1000 Laurel St, San Carlos, CA, 94070
- NPI first listed
- 2019-03-26
- NPI last updated
- 2025-08-15
- NPI record certified
- 2025-08-15
This is when the NPI record was last certified, not a medical board exam.